Rabbit anti-Human GCLM Polyclonal Antibody

Beta LifeScience SKU/CAT #: BLC-04984A
Western Blot analysis of COS7 cells using GCSm-γ Polyclonal Antibody
Western Blot analysis of COS7 cells using GCSm-γ Polyclonal Antibody
Western Blot analysis of MCF-7 cells using GCSm-γ Polyclonal Antibody
Western Blot analysis of MCF-7 cells using GCSm-γ Polyclonal Antibody
Western blot analysis of Mouse-kidney mouse-brain lysis using GCSm-γ antibody.
Western blot analysis of Mouse-kidney mouse-brain lysis using GCSm-γ antibody.

Rabbit anti-Human GCLM Polyclonal Antibody

Beta LifeScience SKU/CAT #: BLC-04984A
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.

Submit an inquiry today to inquire about all available size options and prices! Connect with us via the live chat in the bottom corner to receive immediate assistance.

Product Overview

Product Title Rabbit anti-Human GCLM Polyclonal Antibody
Description The antibody against GCLM was raised in rabbit using the Synthesized peptide derived from the Internal region of Human GCSm-γ. as the immunogen. This antibody exists as a non-conjugated isotype IgG. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This antibody has been validated on WB, IHC, ELISA.
Uniprot Id - Alink P48507
Host Species Rabbit
Reactivity Human, Mouse, Rat, Monkey
Target Name GCLM
Target Synonyms Gamma ECS regulatory subunit antibody; Gamma-ECS regulatory subunit antibody; Gamma-glutamylcysteine synthetase regulatory subunit antibody; GCLM antibody; GCS light chain antibody; GLCLR antibody; Glutamate cysteine ligase regulatory subunit antibody; Glutamate--cysteine ligase modifier subunit antibody; Glutamate--cysteine ligase regulatory subunit antibody; GSC light chain antibody; GSH0_HUMAN antibody
Immunogen Description Synthesized peptide derived from the Internal region of Human GCSm-γ.
Immunogen Species Human
Immunogen Sequence Complete sequences for the immunogen, target protein, and peptides are available upon request.
Conjugate Non-conjugated
Clonality Polyclonal
Isotype IgG
Purification Method The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Buffer Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Form Liquid
Application WB, IHC, ELISA
Storage Conditions Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

FAQs

Please fill out the Online Inquiry form located on the product page. Key product information has been pre-populated. You may also email your questions and inquiry requests to sales1@betalifesci.com. We will do our best to get back to you within 4 business hours.

Feel free to use the Chat function to initiate a live chat. Our customer representative can provide you with a quote immediately.

Proteins are sensitive to heat, and freeze-drying can preserve the activity of the majority of proteins. It improves protein stability, extends storage time, and reduces shipping costs. However, freeze-drying can also lead to the loss of the active portion of the protein and cause aggregation and denaturation issues. Nonetheless, these adverse effects can be minimized by incorporating protective agents such as stabilizers, additives, and excipients, and by carefully controlling various lyophilization conditions.

Commonly used protectant include saccharides, polyols, polymers, surfactants, some proteins and amino acids etc. We usually add 8% (mass ratio by volume) of trehalose and mannitol as lyoprotectant. Trehalose can significantly prevent the alter of the protein secondary structure, the extension and aggregation of proteins during freeze-drying process; mannitol is also a universal applied protectant and fillers, which can reduce the aggregation of certain proteins after lyophilization.

Our protein products do not contain carrier protein or other additives (such as bovine serum albumin (BSA), human serum albumin (HSA) and sucrose, etc., and when lyophilized with the solution with the lowest salt content, they often cannot form A white grid structure, but a small amount of protein is deposited in the tube during the freeze-drying process, forming a thin or invisible transparent protein layer.

Reminder: Before opening the tube cap, we recommend that you quickly centrifuge for 20-30 seconds in a small centrifuge, so that the protein attached to the tube cap or the tube wall can be aggregated at the bottom of the tube. Our quality control procedures ensure that each tube contains the correct amount of protein, and although sometimes you can't see the protein powder, the amount of protein in the tube is still very precise.

To learn more about how to properly dissolve the lyophilized recombinant protein, please visit Lyophilization FAQs.

Recently viewed